Latest News about IMMX
Recent news which mentions IMMX
From Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
May 31, 2022
From Benzinga
88 Biggest Movers From Yesterday
May 27, 2022
From Benzinga
61 Stocks Moving In Thursday's Mid-Day Session
May 26, 2022
From Benzinga
66 Biggest Movers From Friday
May 23, 2022
From Benzinga
From Benzinga
ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug
May 20, 2022
From Benzinga
71 Biggest Movers From Yesterday
May 20, 2022
From Benzinga
From Benzinga
From InvestorPlace
30 Stocks Moving in Monday's Pre-Market Session
May 16, 2022
From Benzinga
51 Biggest Movers From Yesterday
April 06, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 05, 2022
From Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
April 05, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 02, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 02, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 01, 2022
From Benzinga
From InvestorPlace
46 Stocks Moving In Thursday's Mid-Day Session
January 27, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 27, 2022
From Benzinga
41 Biggest Movers From Yesterday
January 27, 2022
From Benzinga
Immix Biopharma's IMX-110 / Anti-PD-1 Combo Therapy Shows Extended Median Survival In Animal Studies
January 25, 2022
From Benzinga
53 Biggest Movers From Friday
January 24, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 19, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 14, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.